Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome

5-Azacytidine (5-AZA) was the first drug to be approved for the treatment of high-risk myelodysplastic syndrome (MDS). The adverse event profile of this drug appears favorable compared with the conventional intensive chemotherapy that is used for MDS or acute myeloid leukemia. However, uncommon adve...

Descripción completa

Detalles Bibliográficos
Autores principales: MELCHARDT, THOMAS, WEISS, LUKAS, PLEYER, LISA, STEINKIRCHNER, SUSANNE, AUBERGER, JUTTA, HOPFINGER, GEORG, GREIL, RICHARD, EGLE, ALEXANDER
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834563/
https://www.ncbi.nlm.nih.gov/pubmed/24260071
http://dx.doi.org/10.3892/ol.2013.1629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834563/
https://www.ncbi.nlm.nih.gov/pubmed/24260071
http://dx.doi.org/10.3892/ol.2013.1629

Ejemplares similares